Opening November 2024
This state-of-the-art facility will feature advanced Molecular Imaging encompassing PET-CT and SPECT-CT.
PET-CT is an essential tool in the diagnosis and management of many cancers including melanoma, lung cancer, lymphomas, breast, colon and prostate cancer.
SPECT-CT plays an enormous role in functional imaging of various organs such as the heart, bones and thyroid.
Soon, we will provide therapy for prostate cancer and neuroendocrine tumours at our new purpose-built theranostic facility.
